ESP National Meeting Highlights Pain Update Series
Release Date: May 22, 2014
Expiration Date: May 22, 2015
Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.
This educational activity offers highlights from key sessions and posters presented at a recent national pain meeting. Key thought leaders summarize the latest information in pain management today. This four module highlight series focuses on the latest data, on what the data means in the clinical setting, and how clinicians may effectively incorporate this information to improve patient care, and ultimately, patient outcomes.
This activity is designed for pain management specialists, as well as primary care specialists, nurses, nurse practitioners, and pharmacists, who provide care to patients with chronic pain.
Upon completion of this educational activity, participants should be able to:
- Summarize recent data regarding safety and efficacy of current and novel approaches to management of chronic pain
- Apply the clinical relevance and potential impact of these findings in the care of patients with chronic pain
- Identify key recommendations from clinical practice guidelines and standardized approaches to therapy with opioids that minimize risk and are designed to optimize outcomes
Acute Pain Antagonizes the Anti-inflammatory Effects of Opioids – Peggy Compton, RN, PhD, FAAN
Informing Clinical Decision Support for Chronic Pain in Primary Care: How Do Physicians Decide When to Initiate Opioids? − Christopher Harle, PhD
Beliefs About Prescribing Opioids for Chronic Pain: Survey of Primary Care Physicians − Robert N. Jamison, PhD
States of Pain: How State Efforts to Eliminate Pill Mills Can Wind Up Hurting People with Pain – Robert Twillman, PhD
Instructions for Participation and Credit
This activity is eligible for credit through May 22, 2015. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.
Peggy Compton, RN, PhD, FAAN
Associate Dean of Academic Affairs
School of Nursing and Health Studies
Dr. Peggy Compton received her BSN from the University of Rochester, her MS from Syracuse University as a clinical nurse specialist, and her PhD in neuroscience nursing from New York University. Following completion of a postdoctoral fellowship at the interdisciplinary UCLA Drug Abuse Research Center, she joined the faculty at the UCLA School of Nursing, where she was promoted to tenured professor. Dr. Compton is professor and associate dean of academic affairs at the Georgetown University School of Nursing and Health Studies. Her areas of clinical expertise are neuroscience, opioids, addiction and pain. She currently serves as principal investigator on NIH-supported grants, and has an active research program exploring pain and opioid addiction with a specific focus on opioid-induced hyperalgesia in chronic pain and opioid dependent individuals.
Christopher Harle, PhD
Department of Health Services Research, Management and Policy
University of Florida
Dr. Christopher Harle received his PhD in information systems and management from the Heinz College of Carnegie Mellon University. He also holds an MS in decision and information sciences from the University of Florida where he is an assistant professor in the Department of Health Services Research, Management and Policy. Dr. Harle's research focus is at the intersection of health information technology, biomedical informatics, and clinical decision making. He is interested in evaluating how patients, consumers, and clinicians use information and technology to make health-related decisions. Currently, he is funded by the NIH KL2 program and Pfizer, Inc. to study primary care clinician decision-making processes and to develop point-of-care decision support tools to improve the quality of care for people with chronic pain. Dr. Harle's work has been published in numerous journals including Medical Decision Making, Journal of the American Medical Informatics Association, Pain Medicine, Journal of General Internal Medicine, Decision Support Systems, and Health Affairs.
Robert N. Jamison, PhD
Harvard Medical School
Departments of Anesthesia, Psychiatry,
and Physical Medicine and Rehabilitation
Brigham and Women's Hospital
Dr. Robert Jamison received his PhD in clinical psychology from the Institute of Psychiatry, University of London. He completed internships in clinical psychology at Bexley Hospital, England, and at Lakeshore Mental Health Institute, Knoxville, Tennessee, as well as a post-doctoral fellowship at Vanderbilt University in Nashville. He is a professor at Harvard Medical School in the Departments of Anesthesia, Psychiatry, and Physical Medicine and Rehabilitation and has over 30 years' experience working with persons with chronic pain. Dr. Jamison is also the chief psychologist at the Pain Management Center at Brigham and Women's Hospital, Boston, where he directs a structured pain management program.
Dr. Jamison is active in many national and international organizations, has been on the Board of Directors for the American Pain Society, and is past president of the New England Pain Association. He has been a surveyor for the Commission on Accreditation of Rehabilitation Facilities and has served as principal investigator in many government and industry-sponsored research studies. He also serves on the editorial boards of five different journals, is a frequent ad hoc reviewer for other established medical journals, and has served as a member of the NIH Behavioral Medicine and NIDA Study Sections. Dr. Jamison has received numerous grants from the NIH and has authored two books, a CD-ROM, and over 200 peer-reviewed articles and chapters in the area of behavioral medicine and chronic pain. He has a long history of mentoring students, fellows, and junior faculty members.
Robert Twillman, PhD
Deputy Executive Director
Director of Policy and Advocacy
American Academy of Pain Management
Dr. Bob Twillman received his PhD in clinical psychology at the University of California in Los Angeles, and maintains a volunteer faculty appointment as clinical associate professor of psychiatry and behavioral sciences at the University of Kansas School of Medicine in Kansas City, Kansas. In addition, Dr. Twillman is the deputy executive director and the director of policy and advocacy for the American Academy of Pain Management where he is responsible for overseeing federal and state pain policy developments and advocating for those supporting an integrative approach to managing pain. He also serves as chair of the Prescription Monitoring Program Advisory Committee for the Kansas Board of Pharmacy. Prior to taking his current position, Dr. Twillman was a full-time faculty member at the University of Kansas Medical Center, where he founded and directed the inpatient pain management program and was a co-founder of the hospital's palliative care team. He has been actively involved in pain policy through his work with the Alliance of State Pain Initiatives and the American Pain Society for many years.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-14-009-H01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 14-009-347
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Accordingly, the following disclosures were made.
Dr. Peggy Compton has disclosed no relevant financial relationships.
Dr. Christopher Harle has received grant support related to research activities from Pfizer Inc.
Dr. Robert Jamison has received grant support related to research activities from Mallinckrodt Pharmaceuticals and Pfizer Inc.
Dr. Robert Twillman has received honoraria related to speakers' bureau activities and as a consultant from Janssen Pharmaceuticals, Inc.
Planning Committee Disclosures
The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.
Peer Reviewer Disclosure
In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Drs. Compton, Harle, Jamison, and Twillman have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.
Drs. Compton, Harle, Jamison, and Twillman have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.
MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player and/or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at email@example.com.
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Purdue Pharma L.P.
©2014 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.